Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Arcturus Therapeutics Holdings (ARCT) Return on Equity (2019 - 2025)

Arcturus Therapeutics Holdings' Return on Equity history spans 7 years, with the latest figure at 0.3% for Q4 2025.

  • For Q4 2025, Return on Equity rose 2.0% year-over-year to 0.3%; the TTM value through Dec 2025 reached 0.3%, up 2.0%, while the annual FY2025 figure was 0.29%, 2.0% up from the prior year.
  • Return on Equity reached 0.3% in Q4 2025 per ARCT's latest filing, down from 0.29% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.38% in Q1 2023 to a low of 0.95% in Q1 2022.
  • Average Return on Equity over 5 years is 0.33%, with a median of 0.3% recorded in 2025.
  • Peak YoY movement for Return on Equity: skyrocketed 133bps in 2023, then crashed -77bps in 2024.
  • A 5-year view of Return on Equity shows it stood at 0.83% in 2021, then skyrocketed by 106bps to 0.05% in 2022, then plummeted by -310bps to 0.11% in 2023, then plummeted by -203bps to 0.32% in 2024, then increased by 7bps to 0.3% in 2025.
  • Per Business Quant, the three most recent readings for ARCT's Return on Equity are 0.3% (Q4 2025), 0.29% (Q3 2025), and 0.26% (Q2 2025).